Source: European Psychiatry. Conference titles: European Congress of Psychiatry. Unidade: FMRP
Subjects: CANABINOIDES, TRANSTORNO OBSESSIVO-COMPULSIVO, SINTOMAS PSÍQUICOS, PSICOMETRIA
ABNT
MORAIS , Eder Roberto de et al. Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder. European Psychiatry. Cambridge: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1192/j.eurpsy.2023.524. Acesso em: 24 out. 2025. , 2023APA
Morais , E. R. de, Zuardi, A. W., Guimarães, F. S., Osório, F. de L., Hallak, J. E. C., Sanches, R. F., & J. A. S. Crippa,. (2023). Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder. European Psychiatry. Cambridge: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1192/j.eurpsy.2023.524NLM
Morais ER de, Zuardi AW, Guimarães FS, Osório F de L, Hallak JEC, Sanches RF, J. A. S. Crippa. Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder [Internet]. European Psychiatry. 2023 ; 66 S225-S226.[citado 2025 out. 24 ] Available from: https://doi.org/10.1192/j.eurpsy.2023.524Vancouver
Morais ER de, Zuardi AW, Guimarães FS, Osório F de L, Hallak JEC, Sanches RF, J. A. S. Crippa. Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder [Internet]. European Psychiatry. 2023 ; 66 S225-S226.[citado 2025 out. 24 ] Available from: https://doi.org/10.1192/j.eurpsy.2023.524
